UK Judge Nixes Patent Extension For Merck HIV Drug
A U.K. judge on Tuesday ruled that a Merck Sharp & Dohme Corp. document extending a patent on the HIV drug Atripla is invalid, in a win for generics makers Teva...To view the full article, register now.
Already a subscriber? Click here to view full article